Pharmacokinetics of CRRT

and Fatemeh Ghane Sharbaf2



(1)
Department of Pediatrics Section of Nephrology, Rush University Medical Center, Chicago, IL, USA

(2)
Department of Pediatrics Section of Nephrology, Mashhad University of Medical Sciences, Mashhad, Iran

 




Drug Removal During CRRT: Basic Principles


Appropriate drug dosing in the acute kidney injury (AKI) patient treated with continuous renal replacement therapies (CRRT) is an important consideration to optimize therapeutic outcomes and to minimize drug toxicity [13]. Underdiagnosed and untreated AKI may lead to chronic kidney disease and end-stage renal disease [4]. When adjusting drug doses for the AKI patient, drug doses should be adjusted based on the renal and CRRT clearance of the drug, the degree of renal impairment, and the potential nephrotoxicity of the prescribed drug. The sum of renal creatinine clearance and CVVH ultrafiltration provides a starting point for subsequent antibiotic dosing. Medication dosing for children with AKI needs to be individualized based on pharmacokinetics and pharmacodynamics principles of the prescribed drugs whenever possible [511]. Both the volume of distribution and half-life of several drugs are markedly increased in the presence of AKI, and thus larger loading doses may need to be administered to achieve the target serum concentration. It is also necessary to know the degree of protein binding and the half-life of the concerned drug. Because of the presence of a positive fluid balance in the early stages of AKI, the dosing regimen for many drugs, especially antimicrobial agents, should be initiated at normal dosage regimens. When available, therapeutic drug monitoring should be used, especially for drugs with low therapeutic index. Guidelines whether or not dose adjustment is required for children with AKI is provided in Table 5.1.


Table 5.1
Pediatric drug dosage adjustments during continuous veno-venous hemofiltration (CVVH)a





































































































































































































































































































































































































































































































































































































































































Drug category

Protein binding (%)

SC

V d L/kg

t 1/2 h

Normal dose (GFR 100)

Dose in CVVH <1–2 L/h GFR < 15–30

Analgesic

Acetaminophen

20–50

0.93

0.2–0.4

2–3

5 mg/kg iv q8h

No change

Acetylsalicylic

>99

50

0.25

0.8

10 mg/kg q4–6h

No change

Codeine

7

NA

3–6

3

0.5–1 mg/kg q6h

75 % dose reduction

Ibuprofen

90–99

NA

0.14

1.8

5–10 mg/kg q6h

No change

Ketorolac

>99

NA

0.1–0.3

5

0.25–1 mg/kg q6h

No change

Fentanyl

80–85

0.29

2.4

2.6

1–5 mcg/kg q6h

75 % dose reduction

Meperidine

60–85

NA

2.4

11

0.5–2 mg/kg infusion

75 % dose reduction

Methadone

60–90

NA

4.5

8–49

0.5 mg/kg q6h

0.5 mg/kg q24h

Morphine

20–35

0.65

3.3

2.5

0.05–0.2 mg/kg iv q2–4h

75 % dose reduction

Antibiotics

Aciclovir

9–33

0.85

0.7

2–3

10 mg/kg iv q8h

Normal dose iv q24h

Amikacinb

<20

0.95

0.2–0.7

1.6-2.5

20 mg/kg (max 1.5 g) iv q24h

10 mg/kg iv q24h

Amoxicillin

15–20

0.85

1.3

5–20

5–15 mg/kg iv q8h

No change

Amphotericin liposomal

90

NA

0.1–0.4

6–10

3–5 mg/kg iv q24h

No change

Ampicillin

17–20

0.8

0.32

1–1.8

50 mg/kg iv q8h

No change

Azithromycin

10–50

NA

NA

6–8

5 mg/kg q12

No change

Aztreonam

50–60

NA

0.25

2

80–120 mg/kg q8h

No change

Benzylpenicillin

60

NA

0.3–0.4

0.5–1.2

25–50 mg/kg iv in q8h

No change

Cefaclor

20–50

NA

0.24–0.35

1

10–20 mg/kg iv q12h

No change

Cefazolin

70–86

NA

0.13–0.22

2

50–100 mg/kg iv q8h

505 dose reduction

Cefotaxime

40

NA

0.3

1.5

50 mg/kg iv q8–12h

No change

Ceftazidime

<10

NA

0.2–0.4

1

25 mg/kg iv q8h

No change

Ceftriaxone

85–95

0.66

0.35

8

80 mg/kg (max 2 g) iv q24h

No change

Cefuroxime

33

0.66

0.19

1.5

25–50 mg/kg iv q8h

25–50 mg/kg iv q12–24 h

Cidofovir

<10

NA

0.3

15–25

5 mg/kg iv q 1–2 weeks

2 mg/kg iv q1-2 weeks

Ciprofloxacin

20–40

0.7

2–3

4–5

10 mg/kg (max 400 mg) iv q12h

25 % reduction q 12 h

Clindamycin

>90

0.4

0.6–1.2

2–3

5–10 mg/kg (max 1.2 g) iv q6h

No change

Co-amoxiclav (amoxicillin + clavulanic acid)

17–30

NA

0.2–0.4

0.9

30 mg/kg (max 1.2 g) iv q8h

50 % dose reduction

Co-trimoxazole (trimethoprim + sulfamethoxazole)

50–66

NA

0.3–2.2

5.5–17

40–60 mg/kg ivq12h

50 % dose reduction

Erythromycin

70–95

0.3

0.6–1.2

2

12.5–25 mg/kg iv q6h

No change

Flucloxacillin

95

NA

0.13

2–3

25–100 mg/kg iv q8h

No change

Fluconazole

12

NA

0.6–1.2

15–20

6–12 mg/kg iv q72h

No change

Ganciclovir

1–2

0.84

0.4–0.8

3–28

5 mg/kg iv q12h

50 % dose reduction

Gentamicinb

1–30

0.95

0.2–0.5

1–3

7 mg/kg iv q24h

4 mg/kg iv q24h

Imipenem

13–21

1

0.5

1–1.3

15 mg/kg (max 500 mg) iv q6h

25 % dose reduction

Isoniazid

10–15

NA

NA

2.8

10–15 mg/kg q12–24h

No change

Ketoconazole

85–99

NA

2–4

8

3–6 mg/kg q24h

No change

Levofloxacin

25–38

0.8

NA

NA

5–10 mg/kg q24h

No change

Meropenem

2

NA

0.4

1.5–2.3

10–20 mg/kg iv q8h

No change

Metronidazole

<20

0.8

1.1

6–12

7.5 mg/kg (max 500 mg) iv q8h

No change

Nafcillin

90

0.2

0.35

1

15–50 mg/kg iv q4–6h

No change

Flaxacillin

20–30

NA

NA

NA

15 mg/kg iv q12h

No change

Piperacillin

20–30

NA

0.2

0.7

200 mg/kg q4h

200 mg/kg q8h

Rifampicin

80

0.2

0.66

1–3.8

10 mg/kg (max 500 mg) iv q12h

No change

Streptomycin

34

NA

NA

5–8

20–40 mg/kg iv q24h

7.5 mg/kg q24h

Ticarcillin

45–65

NA

0.22

1.1

80 mg/kg (max 3.2 g) q8h

No change

Tobramycin

44–50

1.6

1.6

11

60 mg/kg iv q12h

50 % dose reduction

Vancomycinb

55

NA

0.4–0.7

5.6

15 mg/kg iv q8h

10 mg/kg iv q12h

Anticoagulants

Heparinc

95

<0.1

1

2

10–25 U/kg/h

No change

Warfarin

>90

0.02

0.05

50

0.5–8 mg q24h

No change

Anticonvulsants

Carbamazepine

75–90

74

0.25

1.3

5–10 mg/kg q12h

75 % dose reduction

Phenobarbital

30–50

0.6

0.8

80

3–7 mg/kg q24h

10 mg/kg q 6-8 h

Phenytoin

80–90

0.1

0.6

20

3–7 mg/kg q8h

No change

Valproic acid

80–93

0.1

0.2–1

9–16

10–30 mg/kg q12h

No change

Antihistamines

Cimetidine

19

0.8

1

2

4–8 mg/kg q12h

50 % dose reduction

Diphenhydramine

78

NA

3–6

5–11

1 mg/kg q4–6h

No change

Famotidine

15–20

NA

1–1.5

2–4

0.5 mg/kg q12h

No change

Terbutaline

25

NA

1.6

5.7

0.1–0.4 mg/kg/min iv infusion

No change

Antihypertensive agents

Amlodipine

93

NA

21

40

0.05–0.17 mg/kg q24h

No change

Captopril

30

NA

1.5

1.5

0.1–0.5 mg/kg q6–8h

75 % dose reduction

Clonidine

20–40

0.7

2.1

8

2.5–5 mcg/kg q12h

No change

Enalapril

<50

0.5

1.7

11

0.1 mg/kg q12h

75 % dose reduction

Hydralazine

85–90
       
0.15 mg/Kg q8h

Isradipine

95

0.13

1.5

1

0.05–0.2 mg/kg q8h

No change

Labetalol

50
     
0.4–3 mg/h iv infusion

No change

Lisinopril

25

NA

NA

5–6

0.1 mg/kg q12–24h

0.50 % dose reduction

Nifedipine

95 %

0.08

1.2

2.8

0.25–0.5 mg/kg q6–8h

No change

Prazosin

95

0.03

0.6

2.9

0.2–1 mg/kg q12h

No change

Propranolol

60–90

0.07

4.3

3.5

0.1–1 mg/kg q6h

No change

Cardiovascular agents

Amiodarone

96

0.03

61

N/A

5–10 mg/kg q24h

No change

Atenolol

<5

1

0.43

6

1–2 mg/kg q24h

No change

Atropine

14–22

0.5

2.9

2–4

0.5–1 mg q5–30min

No change

Digoxin

20–55

0.8

6.5

40

250 mcg q24h

62.5 mcg q24h

Dobutamine

NA

NA

0.2

2

2–20 mcg/kg/min iv infusion

No change

Dopamine

NA

NA

NA

5.5

2–20 mcg/kg/min iv infusion

No change

Epinephrine

N/A

NA

<0.1

<0.1

0.01–1 mcg/kg/min iv infusion

No change

Milrinone

70

NA

0.38

2.3

0.25–0.75 mcg/kg/min iv infusion

0.33 mcg/kg/min iv infusion

Procainamide

15–20
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 3, 2016 | Posted by in PEDIATRICS | Comments Off on Pharmacokinetics of CRRT

Full access? Get Clinical Tree

Get Clinical Tree app for offline access